The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis
Abstract
Autoimmunity plays a key role in the immunopathogenesis of psoriasis; however, little is known about the recruitment of pathogenic cells to skin lesions. We report here that the CC chemokine, macrophage inflammatory protein-3α, recently renamed CCL20, and its receptor CCR6 are markedly up-regulated in psoriasis. CCL20-expressing keratinocytes colocalize with skin-infiltrating T cells in lesional psoriatic skin. PBMCs derived from psoriatic patients show significantly increased CCR6 mRNA levels. Moreover, skin-homing CLA+ memory T cells express high levels of surface CCR6. Furthermore, the expression of CCR6 mRNA is 100- to 1000-fold higher on sorted CLA+ memory T cells than other chemokine receptors, including CXCR1, CXCR2, CXCR3, CCR2, CCR3, and CCR5. In vitro, CCL20 attracted skin-homing CLA+ T cells of both normal and psoriatic donors; however, psoriatic lymphocytes responded to lower concentrations of chemokine and showed higher chemotactic responses. Using ELISA as well as real-time quantitative PCR, we show that cultured primary keratinocytes, dermal fibroblasts, and dermal microvascular endothelial and dendritic cells are major sources of CCL20, and that the expression of this chemokine can be induced by proinflammatory mediators such as TNF-α/IL-1β, CD40 ligand, IFN-γ, or IL-17. Taken together, these findings strongly suggest that CCL20/CCR6 may play a role in the recruitment of T cells to lesional psoriatic skin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Self-citationβ-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425
Self-citationActivation of human dendritic cells through CD40 cross-linking.
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., & Banchereau, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1263 · Cited by 1,317
Self-citationChemokines and the Arrest of Lymphocytes Rolling Under Flow Conditions
Campbell, J. J., Hedrick, J., Zlotnik, A., Siani, M. A., Thompson, D. A., & Butcher, E. C. (1998) · Science · doi:10.1126/science.279.5349.381 · Cited by 995
Self-citationThe chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
Campbell, J. J., Haraldsen, G., Pan, J., Rottman, J., Qin, S., Ponath, P., Andrew, D. P., Warnke, R., Ruffing, N., Kassam, N., et al. (1999) · Nature · doi:10.1038/23495 · Cited by 841
Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., & Dvorak, H. F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1141 · Cited by 685
Gottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
Teunissen, M. B. M., Bos, J. D., Koomen, C. W., de Waal Malefyt, R., & Wierenga, E. A. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00347.x · Cited by 570
Self-citationCyclosporine Improves Psoriasis in a Double-blind Study
Ellis, C. N. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380220076026 · Cited by 558
Uyemura, K., Yamamura, M., Fivenson, D. F., Modlin, R. L., & Nickoloff, B. J. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371679 · Cited by 450
Dermal injection of immunocytes induces psoriasis.
Wrone-Smith, T., & Nickoloff, B. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118989 · Cited by 439
Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
Nickoloff, B. J., Karabin, G. D., Barker, J. N., Griffiths, C. E. M., Sarma, V. J., Mitra, R. S., Elder, J. T., Kunkel, S. L., & Dixit, V. M. (1991) · PubMed Central · Cited by 430
Liao, F., Rabin, R. L., Smith, C. S., Sharma, G., Nutman, T. B., & Farber, J. M. (1999) · PubMed · Cited by 396
Liao, F., Rabin, R. L., Smith, C. S., Sharma, G., Nutman, T. B., & Farber, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.186 · Cited by 363
Greaves, D. R., Wang, W., Dairaghi, D. J., Dieu, M. C., Saint-Vis, B. D., Franz-Bacon, K., Rossi, D., Caux, C., McClanahan, T., Gordon, S., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.6.837 · Cited by 356
Self-citationRossi, D. L., Vicari, A. P., Franz-Bacon, K., McClanahan, T. K., & Zlotnik, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1033 · Cited by 312
Self-citationNestle, F. O., Turka, L. A., & Nickoloff, B. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117308 · Cited by 306
Vicari, A. P., Figueroa, D. J., Hedrick, J. A., Foster, J. S., Singh, K. P., Menon, S., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Bacon, K. B., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80531-2 · Cited by 287
Self-citationPower, C. A., Church, D. J., Meyer, A., Alouani, S., Proudfoot, A. E. I., Clark-Lewis, I., Sozzani, S., Mantovani, A., & Wells, T. N. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.6.825 · Cited by 282
Charbonnier, A.-S., Kohrgruber, N., Kriehuber, E., Stingl, G., Rot, A., & Maurer, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1755 · Cited by 268
Differential expression of homing-associated adhesion molecules by T cell subsets in man.
Picker, L. J., Terstappen, L. W. M. M., Rott, L. S., Streeter, P. R., Stein, H., & Butcher, E. C. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3247 · Cited by 262
Injection of Pre-Psoriatic Skin with CD4+ T Cells Induces Psoriasis
Nickoloff, B. J., & Wrone-Smith, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65109-7 · Cited by 260
Boismenu, R., Feng, L., Xia, Y. Y., Chang, J. C., & Havran, W. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.985 · Cited by 250
Krueger, J. G., Wolfe, J. T., Nabeya, R. T., Vallat, V. P., Gilleaudeau, P., Heftler, N. S., Austin, L. M., & Gottlieb, A. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.2057 · Cited by 248
The cutaneous features of tuberous sclerosis: a population study
WEBB, D. W., CARKE, A., FYER, A., & OSBORNE, J. P. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-923.x · Cited by 246
Immunocompetent cells in psoriasis: In situ immunophenotyping by monoclonal antibodies
Bos, J. D., Hulsebosch, H. J., Krieg, S. R., Bakker, P. M., & Cormane, R. H. (1983) · Archives of Dermatological Research · doi:10.1007/bf00510050 · Cited by 236
Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques.
Gottlieb, A. B., Luster, A. D., Posnett, D. N., & Carter, D. M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.3.941 · Cited by 225
Bos, J. D., Hagenaars, C., Das, P. K., Krieg, S. R., Voorn, W. J., & Kapsenberg, M. L. (1989) · Archives of Dermatological Research · doi:10.1007/bf00424268 · Cited by 221
Tanaka, Y., Imai, T., Baba, M., Ishikawa, I., Uehira, M., Nomiyama, H., & Yoshie, O. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<633::aid-immu633>3.0.co;2-i · Cited by 203
Upper Keratinocytes of Psoriatic Skin Lesions Express High Levels of NAP-1/IL-8 mRNA In Situ
Gillitzer, R., Berger, R., Mielke, V., Müller, C., Wolff, K., & Stingl, G. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12478128 · Cited by 175
Nickoloff, B. J., Mitra, R. S., Green, J., Zheng, X. G., Shimizu, Y., Thompson, C., & Turka, L. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.6.2148 · Cited by 170
Murine psoriasis-like disorder induced by naive CD4+ T cells
SchÖn, M. P., Detmar, M., & Parker, C. M. (1997) · Nature Medicine · doi:10.1038/nm0297-183 · Cited by 167
Mizutani, H., Ohmoto, Y., Mizutani, T., Murata, M., & Shimizu, M. (1997) · Journal of Dermatological Science · doi:10.1016/s0923-1811(96)00562-2 · Cited by 152
MCP-1 mRNA Expression in Basal Keratinocytes of Psoriatic Lesions
Gillitzer, R., Wolff, K., Castillo‐Tong, D. C., Mueller, C., Yoshimura, T., Hartmann, A., Stingl, G., & Berger, R. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12363613 · Cited by 150
An important role of tumor necrosis factor-α in the induction of adhesion molecules in psoriasis
Terajima, S., Higaki, M., Igarashi, Y., Nogita, T., & Kawashima, M. (1998) · Archives of Dermatological Research · doi:10.1007/s004030050299 · Cited by 150
Gillitzer, R., Ritter, U., Spandau, U. H., Goebeler, M., & Bröcker, E.-B. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371803 · Cited by 143
CD4 antibody treatment of severe psoriasis
Nicolas, J., Chamchick, N., Thivolet, J., Wijdenes, J., Morel, P., & Révillard, J. P. (1991) · The Lancet · doi:10.1016/0140-6736(91)90465-2 · Cited by 131
Animal Models of Psoriasis – What Can We Learn from Them?
Schön, M. P. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00538.x · Cited by 127
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
Schulz, B., Michel, G., Wagner, S. N., Süss, R., Beetz, A., Peter, R. U., Kemény, L. V., & Ruzicka, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4399 · Cited by 120
Self-citationIL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy
Lemster, B. H., Carroll, P. B., Rilo, H., Johnson, N., Nikaein, A., & Thomson, A. W. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05525.x · Cited by 110
The CXC Receptor 2 Is Overexpressed in Psoriatic Epidermis
Kulke, R., Bornscheuer, E., Schlüter, C., Bartels, J., Röwert, J., Sticherling, M., & Christophers, E. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00074.x · Cited by 108
Anti-CD4 monoclonal antibody therapy in severe psoriasis
Morel, P., Revillard, J., Nicolas, J., Wijdenes, J., Rizova, H., & Thivolet, J. (1992) · Journal of Autoimmunity · doi:10.1016/0896-8411(92)90006-c · Cited by 106
Aetiology and pathogenesis of psoriasis
Ortonne, J. ‐. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb15660.x · Cited by 90
The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions
Goebeler, M., Toksoy, A., Spandau, U., Engelhardt, E., Bröcker, E., & Gillitzer, R. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<89::aid-path975>3.0.co;2-z · Cited by 87
Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis
Gomi, T., Shiohara, T., Munakata, T., Imanishi, K., & Nagashima, M. (1991) · Archives of Dermatology · doi:10.1001/archderm.127.6.827 · Cited by 83
Kulke, R., Tödt-Pingel, I., Rademacher, D., Röwert, J., Schröder, J., & Christophers, E. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12343916 · Cited by 67
Chemokine IP-10 expression in cultured human keratinocytes
Boorsma, D. M., Flier, J., Sampat-Sardjoepersad, S. C., Ottevanger, C. F., de Haan, P., Hooft, L., Willemze, R., Tensen, C. P., & Stoof, T. J. (1998) · Archives of Dermatological Research · doi:10.1007/s004030050314 · Cited by 60
Debets, R., Hegmans, J. P., Troost, R. J. J., Benner, R., & Prens, E. P. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250623 · Cited by 60
Bolin, L. M., McNeil, T., Lucian, L., Devaux, B., Franz-Bacon, K., Gorman, D. M., Zurawski, S., Murray, R. M., & McClanahan, T. K. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05493.1997 · Cited by 45
Effects of cyclosporine on immunologic mechanisms in psoriasis
Cooper, K. D., Voorhees, J. J., Fisher, G. J., Chan, L. S., Gupta, A. K., & Baadsgaard, O. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70360-t · Cited by 41
Nickoloff, B. J., Mitra, R. S., Green, J. M., Shimizu, Y., Thompson, C. B., & Turka, L. A. (1993) · Journal of Dermatological Science · doi:10.1016/0923-1811(93)90002-7 · Cited by 31
Cited by
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Tesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Metadata
- Authors
- Homey, B., Dieu-Nosjean, M.-C., Wiesenborn, A., Massacrier, C., Pin, J.-J., Oldham, E., Catron, D., Buchanan, M. E., Müller, A., deWaal Malefyt, R., Deng, G., Orozco, R., Ruzicka, T., Lehmann, P., Lebecque, S., Caux, C., & Zlotnik, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06
- Volume
- 164
- Issue
- 12
- Pages
- 6621-6632
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1534594872
- Cited by
- 537
- References
- 52
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.